These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Technetium-99m-HMPAO, technetium-99m-ECD and iodine-123-IMP cerebral blood flow measurements with pharmacological interventions in primates. Dormehl IC; Oliver DW; Langen KJ; Hugo N; Croft SA J Nucl Med; 1997 Dec; 38(12):1897-901. PubMed ID: 9430465 [TBL] [Abstract][Full Text] [Related]
13. Effects of scatter correction on regional distribution of cerebral blood flow using I-123-IMP and SPECT. Ito H; Iida H; Kinoshita T; Hatazawa J; Okudera T; Uemura K Ann Nucl Med; 1999 Oct; 13(5):331-6. PubMed ID: 10582803 [TBL] [Abstract][Full Text] [Related]
14. [Arterial clearance and cerebral uptake of Tc-99m ECD in patients with cerebrovascular disease compared with PET]. Shishido F; Uemura K; Murakami M; Inugami A; Ogawa T; Higano S; Fujita H; Shimosegawa E; Kanno I; Aizawa Y Kaku Igaku; 1992 Jan; 29(1):27-35. PubMed ID: 1578819 [TBL] [Abstract][Full Text] [Related]
19. 99mTc-bicisate reliably images CBF in chronic brain diseases but fails to show reflow hyperemia in subacute stroke: report of a multicenter trial of 105 cases comparing 133Xe and 99mTc-bicisate (ECD, neurolite) measured by SPECT on same day. Lassen NA; Sperling B J Cereb Blood Flow Metab; 1994 Jan; 14 Suppl 1():S44-8. PubMed ID: 8263071 [TBL] [Abstract][Full Text] [Related]
20. SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD. Koyama M; Kawashima R; Ito H; Ono S; Sato K; Goto R; Kinomura S; Yoshioka S; Sato T; Fukuda H J Nucl Med; 1997 Apr; 38(4):587-92. PubMed ID: 9098207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]